Evidence map›Paper›PMID 21453778›Full record

ArticleNeurobiology of learning and memory2011

Lidocaine attenuates anisomycin-induced amnesia and release of norepinephrine in the amygdala.

Renee N Sadowski, Clint E Canal, Paul E Gold

Abstract read
In one paragraph

Article in Neurobiology of learning and memory, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. ZIP It: Neural Silencing Is an Additional Effect of the PKM-Zeta Inhibitor Zeta-Inhibitory Peptide.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2016
    Article
  4. Intrahippocampal Anisomycin Impairs Spatial Performance on the Morris Water Maze.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2015
    Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Renee N SadowskiNeuroscience Program, College of Medicine, University of Illinois at Urbana-Champaign, Champaign, IL 61820, USA.
Clint E Canal
Paul E Gold
University of Illinois Urbana-Champaign · US

Funding

AGING AND MEMORYR01AG007648 · NIA · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI GOLD, PAUL E. · 1990 to 2008
$1.5M
Protein synthesis inhibitor effects on neurotransmitters and memoryR21DA024129 · NIDA · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI GOLD, PAUL E. · 2007 to 2008
$304k
NIA NIH HHS AG007648NIA NIH HHS R01 AG007648NIDA NIH HHS DA024129NIDA NIH HHS R21 DA024129
6 · The paper itself

Abstract

When administered near the time of training, protein synthesis inhibitors such as anisomycin impair later memory. A common interpretation of these findings is that memory consolidation requires new protein synthesis initiated by training. However, recent findings support an alternative interpretation that abnormally large increases in neurotransmitter release after injections of anisomycin may be responsible for producing amnesia. In the present study, a local anesthetic was administered prior to anisomycin injections in an attempt to mitigate neurotransmitter actions and thereby attenuate the resulting amnesia. Rats received lidocaine and anisomycin injections into the amygdala 130 and 120 min, respectively, prior to inhibitory avoidance training. Memory tests 48 h later revealed that lidocaine attenuated anisomycin-induced amnesia. In other rats, in vivo microdialysis was performed at the site of amygdala infusion of lidocaine and anisomycin. As seen previously, anisomycin injections produced large increases in release of norepinephrine in the amygdala. Lidocaine attenuated the anisomycin-induced increase in release of norepinephrine but did not reverse anisomycin inhibition of protein synthesis, as assessed by c-Fos immunohistochemistry. These findings are consistent with past evidence suggesting that anisomycin causes amnesia by initiating abnormal release of neurotransmitters in response to the inhibition of protein synthesis.

Indexed as

AmnesiaAmygdalaAnesthetics, LocalAnimalsAnisomycinAvoidance LearningLidocaineMaleMemoryNorepinephrineProtein Synthesis InhibitorsRatsRats, Sprague-DawleyAnesthetics, LocalAnisomycinLidocaineNorepinephrineProtein Synthesis Inhibitors

Identifiers

PMID21453778
PMCPMC3148321
OpenAlexW2043670080

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.